Carregant...
Chimeric Antigen Receptor (CAR)-Modified Immune Effector Cell Therapy for Acute Myeloid Leukemia (AML)
SIMPLE SUMMARY: Adoptive cell transfer with chimeric antigen receptor (CAR)-modified immune effector cells (IECs) has quickly emerged as a paradigm-shifting approach for the management of B cell malignancies given its ability to induce high rates of remission. This is reflected by the regulatory app...
Guardat en:
| Publicat a: | Cancers (Basel) |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7761730/ https://ncbi.nlm.nih.gov/pubmed/33287224 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12123617 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|